Evidence map›Paper›PMID 36080438›Full record

ArticleMolecules (Basel, Switzerland)2022

Developing a Chromatographic

Mohamed F Nawar, Alaa F El-Daoushy, Ahmed Ashry, Andreas Türler

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mohamed F NawarDepartment of Chemistry, Biochemistry and Pharmaceutical Sciences, Faculty of Science, University of Bern, Freiestrasse 3, CH-3012 Bern, Switzerland.ORCID 0000-0003-2786-4530
Alaa F El-DaoushyRadioactive Isotopes and Generators Department, Hot Laboratories Center, Egyptian Atomic Energy Authority, Cairo 13759, Egypt.ORCID 0000-0003-3028-457X
Ahmed AshryRadiation Protection and Civil Defense Department, Nuclear Research Center, Egyptian Atomic Energy Authority, Cairo 13759, Egypt.ORCID 0000-0001-6296-7637
Andreas TürlerDepartment of Chemistry, Biochemistry and Pharmaceutical Sciences, Faculty of Science, University of Bern, Freiestrasse 3, CH-3012 Bern, Switzerland.ORCID 0000-0002-4274-1056

Funding

Swiss National Science Foundation CRSII5_180352The Swiss Government Excellence fellowships program 2017.1028
6 · The paper itself

Abstract

The commercial low-pressure column chromatographic

Indexed as

Aluminum OxideTechnetiumMolybdenumRadioisotopesRadiopharmaceuticalsAluminum OxideMolybdenumRadioisotopesRadiopharmaceuticalsTechnetium99Tc generatorsindustrial radiotracersLSA 99Momesoporous alumina

Identifiers

PMID36080438
PMCPMC9457712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.